美国FDA质量管理体系QSR820咨询返回首页
美国《联邦规章典集》（CFR）第21篇“食品与药品”总目
概述：美国《联邦规章典集》（Code of Federal
Regulations，CFR）第21篇“食品与药品”（Title 21―Food and
Drugs）共有9卷（Volume）、3章（Chapter）、1499部（Parts）。其中：第1―8卷第1章第1―1299部，为健康与人类服务
部食品与药品管理局（Food and Drug Administration，Department of Health and Human
Services）的规章；第9卷第2章第1300―1399部，为司法部毒品强制执行局（Drug Enforcement
Administration，Department of
Justice）的规章；第9卷第3章第1400―1499部，为毒品控制政策办公室（Office of National Drug Control
Policy）的规章。
第21篇“食品与药品”（Title 21―Food and Drugs）的概况
卷（Volume） 章（Chapter） 部（Parts） 规制机关（Regulatory Entity）
1 Ⅰ 1-99 健康与人类服务部食品与药品管理局（FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES）
2 100-169
3 170-199
4 200-299
5 300-499
6 500-599
7 600-799
8 800-1299
9 Ⅱ 1300-1399 司法部毒品强制执行局（Drug Enforcement Administration，Department of Justice）
Ⅲ 1400-1499 毒品控制政策办公室（Office of National Drug Control Policy）
部(Part) 中译文 原英文
第Ⅰ章―健康与人类服务部食品与药品管理局（CHAPTER Ⅰ―FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES）
第A分章―总则（SUBCHAPTER A―GENERAL）
1 一般强制执行规章 GENERAL ENFORCEMENT REGULATIONS
2 一般行政规则与决定 GENERAL ADMINISTRATIVE RULINGS AND DECISIONS
3 产品管辖权 PRODUCT JURISDICTION
5 组织 ORGANIZATION
7 强制执行政策 ENFORCEMENT POLICY
10 行政规范与程序 ADMINISTRATIVE PRACTICES AND PROCEDURES
11 电子化记录；电子化签名 ELECTRONIC RECORDS; ELECTRONIC SIGNATURES
12 正式证据的公众听证 FORMAL EVIDENTIARY PUBLIC HEARING
13 在公众质询委员会前的公众听证 PUBLIC HEARING BEFORE A PUBLIC BOARD OF INQUIRY
14 在公众咨询委员会前的公众听证 PUBLIC HEARING BEFORE A PUBLIC ADVISORY COMMITTEE
15 在FDA局长前的公众听证 PUBLIC HEARING BEFORE THE COMMISSIONER
16 在FDA前的规制性听证 REGULATORY HEARING BEFORE THE FOOD AND DRUG ADMINISTRATION
17 行政罚款听证 CIVIL MONEY PENALTIES HEARINGS
19 行为标准与利益冲突 STANDARDS OF CONDUCT AND CONFLICTS OF INTEREST
20 公共信息 PUBLIC INFORMATION
21 隐私保护 PROTECTION OF PRIVACY
25 环境影响考虑 ENVIRONMENTAL IMPACT CONSIDERATIONS
26 药品良好制造规范报告、医疗器械质量体系核查报告以及某些医疗器械产品评价报告的互认：美国与欧共体 MUTUAL RECOGNITION OF PHARMACEUTICAL GOOD MANUFACTURING PRACTICE REPORTS, MEDICAL DEVICE QUALITY SYSTEM AUDIT REPORTS, AND CERTAIN MEDICAL DEVICE PRODUCT EVALUATION REPORTS: UNITED STATES AND THE EUROPEAN COMMUNITY
50 人类受试者的保护 PROTECTION OF HUMAN SUBJECTS
54 临床试验者的财务公开 FINANCIAL DISCLOSURE BY CLINICAL INVESTIGATORS
56 机构审查委员会 INSTITUTIONAL REVIEW BOARDS
58 对非临床实验室研究的良好实验室规范 GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY STUDIES
60 专利期恢复 PATENT TERM RESTORATION
70 色素添加剂 COLOR ADDITIVES
71 色素添加剂申请 COLOR ADDITIVE PETITIONS
73 免除认证的色素添加剂的列表 LISTING OF COLOR ADDITIVES EXEMPT FROM CERTIFICATION
74 适用认证的色素添加剂的列表 LISTING OF COLOR ADDITIVES SUBJECT TO CERTIFICATION
80 色素添加剂认证 COLOR ADDITIVE CERTIFICATION
81 用于食品、药品和化妆品的临时性色素添加剂的一般规范和一般限制 GENERAL SPECIFICATIONS AND GENERAL RESTRICTIONS FOR PROVISIONAL COLOR ADDITIVES FOR USE IN FOODS, DRUGS, AND COSMETICS
82 经认证的临时性列表的色素和规范的列表 LISTING OF CERTIFIED PROVISIONALLY LISTED COLORS AND SPECIFICATIONS
83-98 [预留的] [Reserved]
99 已上市的药品、生物制品和器械的未经批准的/新的用途的信息的发布 DISSEMINATION OF INFORMATION ON UNAPPROVED/NEW USES FOR MARKETED DRUGS, BIOLOGICS, AND DEVICES
第B分章―用于人类消费的食品（SUBCHAPTER B―FOOD FOR HUMAN CONSUMPTION）
100 总则 GENERAL
101 食品标识 FOOD LABELING
102 非标准化食品的普通的或者通常的名称 COMMON OR USUAL NAME FOR NONSTANDARDIZED FOODS
104 食品的营养质量指南 NUTRITIONAL QUALITY GUIDELINES FOR FOODS
105 特殊膳食用途的食品 FOODS FOR SPECIAL DIETARY USE
106 婴儿配方母乳替代食品质量控制程序 INFANT FORMULA QUALITY CONTROL PROCEDURES
107 婴儿配方母乳替代食品 INFANT FORMULA
108 紧急许可控制 EMERGENCY PERMIT CONTROL
109 在人类食品与食品-包装材料中的不可避免的污染物 UNAVOIDABLE CONTAMINANTS IN FOOD FOR HUMAN CONSUMPTION AND FOOD-PACKAGING MATERIAL
110 在制造、包装或者保存人类食品中的现行良好制造规范 CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKING, OR HOLDING HUMAN FOOD
113 装在密封容器中的热加工低酸食品 THERMALLY PROCESSED LOW-ACID FOODS PACKAGED IN HERMETICALLY SEALED CONTAINERS
114 酸化食品 ACIDIFIED FOODS
115 带壳蛋 SHELL EGGS
119 存在显著或者不合理风险的膳食补充剂 DIETARY SUPPLEMENTS THAT PRESENT A SIGNIFICANT OR UNREASONABLE RISK
120 危害分析与关键控制点（HACCP）体系 HAZARD ANALYSIS AND CRITICAL CONTROL POINT (HACCP) SYSTEMS
123 鱼与渔业产品 FISH AND FISHERY PRODUCTS
129 饮用水加工与装瓶 PROCESSING AND BOTTLING OF BOTTLED DRINKING WATER
130 食品标准：总则 FOOD STANDARDS: GENERAL
131 乳与奶油 MILK AND CREAM
133 乳酪与相关乳酪产品 CHEESES AND RELATED CHEESE PRODUCTS
135 冷冻点心 FROZEN DESSERTS
136 烘焙产品 BAKERY PRODUCTS
137 谷物粉与相关产品 CEREAL FLOURS AND RELATED PRODUCTS
139 通心粉与面条产品 MACARONI AND NOODLE PRODUCTS
145 罐装水果 CANNED FRUITS
146 罐装水果汁 CANNED FRUIT JUICES
150 水果黄油、果冻、防腐剂以及相关产品 FRUIT BUTTERS, JELLIES, PRESERVES, AND RELATED PRODUCTS
152 水果馅饼 FRUIT PIES
155 罐装蔬菜 CANNED VEGETABLES
156 蔬菜汁 VEGETABLE JUICES
158 冷冻蔬菜 FROZEN VEGETABLES
160 蛋与蛋制品 EGGS AND EGG PRODUCTS
161 鱼与有壳的水生动物 FISH AND SHELLFISH
163 可可制品 CACAO PRODUCTS
164 树坚果与花生制品 TREE NUT AND PEANUT PRODUCTS
165 饮料 BEVERAGES
166 人造黄油 MARGARINE
168 增甜剂与餐桌糖浆 SWEETENERS AND TABLE SIRUPS
169 食品敷料与调味料 FOOD DRESSINGS AND FLAVORINGS
170 食品添加剂 FOOD ADDITIVES
171 食品添加剂申请 FOOD ADDITIVE PETITIONS
172 允许直接加入用于人类消费食品的食品添加剂 FOOD ADDITIVES PERMITTED FOR DIRECT ADDITION TO FOOD FOR HUMAN CONSUMPTION
173 在用于人类消费的食品中允许的次直接的食品添加剂 SECONDARY DIRECT FOOD ADDITIVES PERMITTED IN FOOD FOR HUMAN CONSUMPTION
174 间接食品添加剂：总则 INDIRECT FOOD ADDITIVES: GENERAL
175 间接食品添加剂：胶粘剂与涂层的组分 INDIRECT FOOD ADDITIVES: ADHESIVES AND COMPONENTS OF COATINGS
176 间接食品添加剂：纸与纸板组分 INDIRECT FOOD ADDITIVES: PAPER AND PAPERBOARD COMPONENTS
177 间接食品添加剂：聚合体 INDIRECT FOOD ADDITIVES: POLYMERS
178 间接食品添加剂：辅剂、生产助剂和消毒剂 INDIRECT FOOD ADDITIVES: ADJUVANTS, PRODUCTION AIDS, AND SANITIZERS
179 在食品生产、加工和处理中的辐照 IRRADIATION IN THE PRODUCTION, PROCESSING AND HANDLING OF FOOD
180 在额外试验期间临时在食品或者在与食品接触中被允许的食品添加剂 FOOD ADDITIVES PERMITTED IN FOOD OR IN CONTACT WITH FOOD ON AN INTERIM BASIS PENDING ADDITIONAL STUDY
181 先前核准的食品配料 PRIOR-SANCTIONED FOOD INGREDIENTS
182 一般认为安全的物质 SUBSTANCES GENERALLY RECOGNIZED AS SAFE
184 被确认为一般认为安全的直接食品物质 DIRECT FOOD SUBSTANCES AFFIRMED AS GENERALLY RECOGNIZED AS SAFE
186 被确认为一般认为安全的间接食品物质 INDIRECT FOOD SUBSTANCES AFFIRMED AS GENERALLY RECOGNIZED AS SAFE
189 禁止用于人类食品的物质 SUBSTANCES PROHIBITED FROM USE IN HUMAN FOOD
190 膳食补充剂 DIETARY SUPPLEMENTS
191-199 [预留的] [Reserved]
第C分章―药品：总则（SUBCHAPTER C―DRUGS: GENERAL）
200 总则 GENERAL
201 标识 LABELING
202 处方药广告 PRESCRIPTION DRUG ADVERTISING
203 处方药销售 PRESCRIPTION DRUG MARKETING
205 对批发处方药销售商颁发州执照的指南 GUIDELINES FOR STATE LICENSING OF WHOLESALE PRESCRIPTION DRUG DISTRIBUTORS
206 人用固体口服剂型药品的印码 IMPRINTING OF SOLID ORAL DOSAGE FORM DRUG PRODUCTS FOR HUMAN USE
207 药品生产者的登记与商业销售的药品的列表 REGISTRATION OF PRODUCERS OF DRUGS AND LISTING OF DRUGS IN COMMERCIAL DISTRIBUTION
208 处方药的药物治疗指导 MEDICATION GUIDES FOR PRESCRIPTION DRUG PRODUCTS
210 制造、加工、包装或者保存药品的现行良好制造规范；总则 CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PROCESSING, PACKING, OR HOLDING OF DRUGS; GENERAL
211 对完成的药品的现行良好制造规范 CURRENT GOOD MANUFACTURING PRACTICE FOR FINISHED PHARMACEUTICALS
216 药房配药 PHARMACY COMPOUNDING
225 对含药饲料的现行良好制造规范 CURRENT GOOD MANUFACTURING PRACTICE FOR MEDICATED FEEDS
226 对A型含药物品的现行良好制造规范 CURRENT GOOD MANUFACTURING PRACTICE FOR TYPE A MEDICATED ARTICLES
250 对特殊人用药品的特殊要求 SPECIAL REQUIREMENTS FOR SPECIFIC HUMAN DRUGS
290 管制的药品 CONTROLLED DRUGS
299 药品；正式名称与已确定的名称 DRUGS; OFFICIAL NAMES AND ESTABLISHED NAMES
第D分章―人用药品（SUBCHAPTER D―DRUGS FOR HUMAN USE）
300 总则 GENERAL
310 新药 NEW DRUGS
312 试验用新药申请 INVESTIGATIONAL NEW DRUG APPLICATION
314 为FDA批准上市新药的申请 APPLICATIONS FOR FDA APPROVAL TO MARKET A NEW DRUG
315 诊断用放射性药品 DIAGNOSTIC RADIOPHARMACEUTICALS
316 罕见病药 ORPHAN DRUGS
320 生物利用度与生物等效性要求 BIOAVAILABILITY AND BIOEQUIVALENCE REQUIREMENTS
328 含有酒精的预期用于口部摄入的非处方药品 OVER-THE-COUNTER DRUG PRODUCTS INTENDED FOR ORAL INGESTION THAT CONTAIN ALCOHOL
330 一般认为安全与有效以及不错误标识的非处方人用药品 OVER-THE-COUNTER (OTC) HUMAN DRUGS WHICH ARE GENERALLY RECOGNIZED AS SAFE AND EFFECTIVE AND NOT MISBRANDED
331 用于非处方的人类使用的抗酸产品 ANTACID PRODUCTS FOR OVER-THE-COUNTER (OTC) HUMAN USE
332 用于非处方的人类使用的抗胃肠气胀产品 ANTIFLATULENT PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
333 用于非处方的人类使用的局部抗菌药品 TOPICAL ANTIMICROBIAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
335 用于非处方的人类使用的止泻药品 ANTIDIARRHEAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
336 用于非处方的人类使用的止吐药品 ANTIEMETIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
338 用于非处方的人类使用的帮助夜间睡眠的药品 NIGHTTIME SLEEP-AID DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
340 用于非处方的人类使用的兴奋药品 STIMULANT DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
341 用于非处方的人类使用的感冒、咳嗽、过敏症药、支气管扩张以及平喘药品 COLD, COUGH, ALLERGY, BRONCHODILATOR, AND ANTIASTHMATIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
343 用于非处方的人类使用的内服的止痛、退热以及抗风湿药品 INTERNAL ANALGESIC, ANTIPYRETIC, AND ANTIRHEUMATIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
344 用于非处方的人类使用的局部的耳部药品 TOPICAL OTIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
346 用于非处方的人类使用的肛肠药品 ANORECTAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
347 用于非处方的人类使用的皮肤保护药品 SKIN PROTECTANT DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
348 用于非处方的人类使用的外部的止痛药品 EXTERNAL ANALGESIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
349 用于非处方的人类使用的眼科药品 OPHTHALMIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
350 用于非处方的人类使用的止汗药品 ANTIPERSPIRANT DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
352 用于非处方的人类使用的遮光药品 SUNSCREEN DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE [STAYED INDEFINITELY]
355 用于非处方的人类使用的防龋药品 ANTICARIES DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
357 用于非处方的人类使用的其他内服药品 MISCELLANEOUS INTERNAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
358 用于非处方的人类使用的其他外用药品 MISCELLANEOUS EXTERNAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
361 一般认为安全与有效以及不错误标识的处方人用药品：用于研究的药品 PRESCRIPTION DRUGS FOR HUMAN USE GENERALLY RECOGNIZED AS SAFE AND EFFECTIVE AND NOT MISBRANDED: DRUGS USED IN RESEARCH
369 在用于非处方销售的药品与器械上关于警告的解释性声明 INTERPRETATIVE STATEMENTS RE WARNINGS ON DRUGS AND DEVICES FOR OVER-THE-COUNTER SALE
370-499 [预留的] [Reserved]
第E分章―动物药品、饮料和相关产品（SUBCHAPTER E―ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS）
500 总则 GENERAL
501 动物食品标识 ANIMAL FOOD LABELING
502 非标准化的动物食品的普通的或通常的名称 COMMON OR USUAL NAMES FOR NONSTANDARDIZED ANIMAL FOODS
509 在动物食品与食品-包装材料中的不可避免的污染物 UNAVOIDABLE CONTAMINANTS IN ANIMAL FOOD AND FOOD-PACKAGING MATERIAL
510 新动物药 NEW ANIMAL DRUGS
511 作为试验用途的新动物药 NEW ANIMAL DRUGS FOR INVESTIGATIONAL USE
514 新动物药申请 NEW ANIMAL DRUG APPLICATIONS
515 含药饲料厂执照 MEDICATED FEED MILL LICENSE
520 口服剂型的新动物药 ORAL DOSAGE FORM NEW ANIMAL DRUGS
522 植入或者注射剂型的新动物药 IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS
524 眼科和局部剂型的新动物药 OPHTHALMIC AND TOPICAL DOSAGE FORM NEW ANIMAL DRUGS
526 乳房内的剂型 INTRAMAMMARY DOSAGE FORMS
529 某些其他剂型的新动物药 CERTAIN OTHER DOSAGE FORM NEW ANIMAL DRUGS
530 在动物中的特别标签药品使用 EXTRALABEL DRUG USE IN ANIMALS
556 在食品中新动物药残留的容许量 TOLERANCES FOR RESIDUES OF NEW ANIMAL DRUGS IN FOOD
558 用于动物饲料的新动物药 NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS
564 [预留的] [Reserved]
570 食品添加剂 FOOD ADDITIVES
571 食品添加剂申请 FOOD ADDITIVE PETITIONS
573 在动物饲料与饮用水中允许的食品添加剂 FOOD ADDITIVES PERMITTED IN FEED AND DRINKING WATER OF ANIMALS
579 在动物饲料和宠物食品的生产、加工和处理中的辐照 IRRADIATION IN THE PRODUCTION, PROCESSING, AND HANDLING OF ANIMAL FEED AND PET FOOD
582 一般认为安全的物质 SUBSTANCES GENERALLY RECOGNIZED AS SAFE
584 在动物饲料与饮用水中被确认为一般认为安全的食品物质 FOOD SUBSTANCES AFFIRMED AS GENERALLY RECOGNIZED AS SAFE IN FEED AND DRINKING WATER OF ANIMALS
589 禁止用于动物食品或者饲料的物质 SUBSTANCES PROHIBITED FROM USE IN ANIMAL FOOD OR FEED
590-599 [预留的] [Reserved]
第F分章―生物制品（SUBCHAPTER F―BIOLOGICS）
600 生物制品：总则 BIOLOGICAL PRODUCTS: GENERAL
601 颁发执照 LICENSING
606 对血液与血液组分的现行良好制造规范 CURRENT GOOD MANUFACTURING PRACTICE FOR BLOOD AND BLOOD COMPONENTS
607 对人类血液与血液制品的制造者的机构登记与产品列表 ESTABLISHMENT REGISTRATION AND PRODUCT LISTING FOR MANUFACTURERS OF HUMAN BLOOD AND BLOOD PRODUCTS
610 普通生物制品标准 GENERAL BIOLOGICAL PRODUCTS STANDARDS
630 对血液、血液组分和血液衍生物的一般要求 GENERAL REQUIREMENTS FOR BLOOD, BLOOD COMPONENTS, AND BLOOD DERIVATIVES
640 对人类血液和血液制品的附加标准 ADDITIONAL STANDARDS FOR HUMAN BLOOD AND BLOOD PRODUCTS
660 对用于实验室检测的诊断物质的附加标准 ADDITIONAL STANDARDS FOR DIAGNOSTIC SUBSTANCES FOR LABORATORY TESTS
680 对其他产品的附加标准 ADDITIONAL STANDARDS FOR MISCELLANEOUS PRODUCTS
第G分章―化妆品（SUBCHAPTER G―COSMETICS）
700 总则 GENERAL
701 化妆品标识 COSMETIC LABELING
710 化妆品机构的自愿登记 VOLUNTARY REGISTRATION OF COSMETIC PRODUCT ESTABLISHMENTS
720 化妆品配料构成声明的自愿存档 VOLUNTARY FILING OF COSMETIC PRODUCT INGREDIENT COMPOSITION STATEMENTS
740 化妆品警告声明 COSMETIC PRODUCT WARNING STATEMENTS
741-799 [预留的] [Reserved]
第H分章―医疗器械（SUBCHAPTER H―MEDICAL DEVICES）
800 总则 GENERAL
801 标识 LABELING
803 医疗器械报告 MEDICAL DEVICE REPORTING
806 医疗器械；改正与移动的报告 MEDICAL DEVICES; REPORTS OF CORRECTIONS AND REMOVALS
807 对器械的制造者与首次进口者的机构登记与器械列表 ESTABLISHMENT REGISTRATION AND DEVICE LISTING FOR MANUFACTURERS AND INITIAL IMPORTERS OF DEVICES
808 对州和地方医疗器械要求的联邦优先权的豁免 EXEMPTIONS FROM FEDERAL PREEMPTION OF STATE AND LOCAL MEDICAL DEVICE REQUIREMENTS
809 人用体外诊断产品 IN VITRO DIAGNOSTIC PRODUCTS FOR HUMAN USE
810 医疗器械召回权 MEDICAL DEVICE RECALL AUTHORITY
812 试验用器械豁免 INVESTIGATIONAL DEVICE EXEMPTIONS
813 [预留的] [Reserved]
814 医疗器械的上市前批准 PREMARKET APPROVAL OF MEDICAL DEVICES
820 质量体系规章 QUALITY SYSTEM REGULATION
821 医疗器械跟踪要求 MEDICAL DEVICE TRACKING REQUIREMENTS
822 上市后监视 POSTMARKET SURVEILLANCE
860 医疗器械分类程序 MEDICAL DEVICE CLASSIFICATION PROCEDURES
861 性能标准制定程序 PROCEDURES FOR PERFORMANCE STANDARDS DEVELOPMENT
862 临床化学与临床毒理学器械 CLINICAL CHEMISTRY AND CLINICAL TOXICOLOGY DEVICES
864 血液学与病理学器械 HEMATOLOGY AND PATHOLOGY DEVICES
866 免疫学与微生物学器械 IMMUNOLOGY AND MICROBIOLOGY DEVICES
868 麻醉学器械 ANESTHESIOLOGY DEVICES
870 心血管器械 CARDIOVASCULAR DEVICES
872 牙科器械 DENTAL DEVICES
874 耳、鼻和咽器械 EAR, NOSE, AND THROAT DEVICES
876 胃肠病学-泌尿学器械 GASTROENTEROLOGY-UROLOGY DEVICES
878 普通与整形外科器械 GENERAL AND PLASTIC SURGERY DEVICES
880 普通医院与个人使用器械 GENERAL HOSPITAL AND PERSONAL USE DEVICES
882 神经学器械 NEUROLOGICAL DEVICES
884 产科与妇科学器械 OBSTETRICAL AND GYNECOLOGICAL DEVICES
886 眼科器械 OPHTHALMIC DEVICES
888 矫形外科器械 ORTHOPEDIC DEVICES
890 内科学器械 PHYSICAL MEDICINE DEVICES
892 放射学器械 RADIOLOGY DEVICES
895 禁止的器械 BANNED DEVICES
898 电极铅线与患者电缆的性能标准 PERFORMANCE STANDARD FOR ELECTRODE LEAD WIRES AND PATIENT CABLES
第I分章―乳房造影质量标准法（SUBCHAPTER I―MAMMOGRAPHY QUALITY STANDARDS ACT）
900 乳房造影法 MAMMOGRAPHY
第J分章―放射学的健康（SUBCHAPTER J―RADIOLOGICAL HEALTH）
1000 总则 GENERAL
1002 记录与报告 RECORDS AND REPORTS
1003 缺陷与未能守法的通报 NOTIFICATION OF DEFECTS OR FAILURE TO COMPLY
1004 电子产品的回购、修理或者置换 REPURCHASE, REPAIRS, OR REPLACEMENT OF ELECTRONIC PRODUCTS
1005 电子产品的进口 IMPORTATION OF ELECTRONIC PRODUCTS
1010 电子产品的性能标准：总则 PERFORMANCE STANDARDS FOR ELECTRONIC PRODUCTS: GENERAL
1020 电离辐射发生产品的性能标准 PERFORMANCE STANDARDS FOR IONIZING RADIATION EMITTING PRODUCTS
1030 微波与射电频率发生产品的性能标准 PERFORMANCE STANDARDS FOR MICROWAVE AND RADIO FREQUENCY EMITTING PRODUCTS
1040 发光产品的性能标准 PERFORMANCE STANDARDS FOR LIGHT-EMITTING PRODUCTS
1050 声波、次声波和超声波发生产品的性能标准 PERFORMANCE STANDARDS FOR SONIC, INFRASONIC, AND ULTRASONIC RADIATION-EMITTING PRODUCTS
第K分章―[预留的]（SUBCHAPTER K―[RESERVED]）
第 L分章―根据由食品与药品管理局行政执行的某些其他法的规章（SUBCHAPTER L―REGULATIONS UNDER CERTAIN OTHER ACTS ADMINISTERED BY THE FOOD AND DRUG ADMINISTRATION）
1210 根据《联邦进口乳法》的规章 REGULATIONS UNDER THE FEDERAL IMPORT MILK ACT
1230 根据《联邦腐蚀性毒物法》的规章 REGULATIONS UNDER THE FEDERAL CAUSTIC POISON ACT
1240 传染病的控制 CONTROL OF COMMUNICABLE DISEASES
1250 州际运输卫生 INTERSTATE CONVEYANCE SANITATION
1251-1269 [预留的] [Reserved]
1270 预期用于移植的人体组织 HUMAN TISSUE INTENDED FOR TRANSPLANTATION
1271 人体细胞、组织以及细胞的和基于组织的产品 HUMAN CELLS, TISSUES, AND CELLULAR AND TISSUE-BASED PRODUCTS
1272-1299 [预留的] [Reserved]
第Ⅱ章―司法部毒品强制执行局（CHAPTER Ⅱ―DRUG ENFORCEMENT ADMINISTRATION, DEPARTMENT OF JUSTICE）
1300 定义 DEFINITIONS
1301 管制物质的制造者、分销者和调剂者的登记 REGISTRATION OF MANUFACTURERS, DISTRIBUTORS, AND DISPENSERS OF CONTROLLED SUBSTANCES
1302 对管制物质的标识与包装要求 LABELING AND PACKAGING REQUIREMENTS FOR CONTROLLED SUBSTANCES
1303 定额 QUOTAS
1304 登记者的记录与报告 RECORDS AND REPORTS OF REGISTRANTS
1305 令的格式 ORDER FORMS
1306 处方 PRESCRIPTIONS
1307 杂项 MISCELLANEOUS
1308 管制物质的表 SCHEDULES OF CONTROLLED SUBSTANCES
1309 表I化学品的制造者、分销者、进口者和出口者的登记 REGISTRATION OF MANUFACTURERS, DISTRIBUTORS, IMPORTERS AND EXPORTERS OF LIST I CHEMICALS
1310 列入表的化学品和某些机器的记录与报告 RECORDS AND REPORTS OF LISTED CHEMICALS AND CERTAIN MACHINES
1311 [预留的] [Reserved]
1312 管制物质的进口与出口 IMPORTATION AND EXPORTATION OF CONTROLLED SUBSTANCES
1313 前体与必要化学品的进口与出口 IMPORTATION AND EXPORTATION OF PRECURSORS AND ESSENTIAL CHEMICALS
1314-1315 [预留的] [Reserved]
1316 行政职能、规范和程序 ADMINISTRATIVE FUNCTIONS, PRACTICES, AND PROCEDURES
第Ⅲ章―毒品控制政策办公室（CHAPTER Ⅲ―Office of National Drug Control Policy）
1400 [预留的] [Reserved]
1401 信息的公众可及性 PUBLIC AVAILABILITY OF INFORMATION
1402 强制性解密审查 MANDATORY DECLASSIFICATION REVIEW
1403 对给予州和地方政府资金和合作协议的统一行政要求 UNIFORM ADMINISTRATIVE REQUIREMENTS FOR GRANTS AND COOPERATIVE AGREEMENTS TO STATE AND LOCAL GOVERNMENTS
1404 政府范围的排除与暂停（非获得） GOVERNMENTWIDE DEBARMENT AND SUSPENSION (NONPROCUREMENT)
1405 对无毒品工作场所的政府范围的要求（财政援助） GOVERNMENTWIDE REQUIREMENTS FOR DRUG-FREE WORKPLACE (FINANCIAL ASSISTANCE)
1406-1499 [预留的] [Reserved]
上一篇：QSR 820 法规的修改历史
